G6PD Deficiency and Coronavirus (COVID-19)

The Novel Coronavirus poses new challenges to G6PD deficient persons.
Medications that are being experimented with and, in some places, used might be of great risk to G6PD deficients.
We list here recent related studies of Corornavirus drugs, some of them are of great risk, others have not been tested yet.
The listed studies are in both English and Italian. No translations are available.

Articles in Italian

Articles in English

Therapeutic Treatments Currently Experimented

  • Inovio's INO-4800
  • Hydroxychloroquine
  • Ruxolitinib
  • Ozone therapy
  • Chloroquine
  • Tocilizumab